3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
3
Brain Neoplasms
3
Glioma
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Oligodendroglioma
1
Neuritis
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Astrocytoma
1
Interventions
Cyclophosphamide
17
fludarabine phosphate
12
Rituximab
12
Peripheral Blood Stem Cell Transplantation
12
Filgrastim
11
Cyclosporine
11
Whole-Body Irradiation
8
Mycophenolic Acid
8
Radiotherapy
7
Busulfan
7
Antilymphocyte Serum
7
Vincristine
6
Prednisone
6
Melphalan
6
Etoposide
6
Methotrexate
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cord Blood Stem Cell Transplantation
4
Therapeutics
3
Magnetic Resonance Spectroscopy
3
Granulocyte Colony-Stimulating Factor
3
Doxorubicin
3
Cytarabine
3
Carmustine
3
Aprepitant
3
Analgesia
3
plerixafor
2
Vindesine
2
Tacrolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, Large B-Cell, Diffuse
×
Diffusion Tensor Imaging
×
Clear all
NCT03121456
2023-11-13
LYMPHODTECT
Centre Antoine Lacassagne
Phase NA
Unknown
74 enrolled